N4 Pharma Plc (N4P.L) Stock Price
£0.375 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
7 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on N4 Pharma Plc, AI stock picks, stock alerts and much more.
N4P.L AI Stock Analysis
AI stock analysis for N4P.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like N4 Pharma Plc (N4P.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
N4 Pharma Plc (N4P.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of N4 Pharma Plc (N4P.L), currently trading at £0.375, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About N4P.L
-
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom.
-
Symbol
N4P.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
3.1M
Similar Stocks
 |
Shield Therapeutics STX.L |
£3.55 3.1% |
5 |
 |
Indivior PLC INDV.L |
£1198 1.9% |
5 |
 |
Haleon plc HLN.L |
£358.7 0% |
7 |
 |
HUTCHMED (China) Limited HCM.L |
£258 2.4% |
5 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£2010 0.8% |
6 |
News
N4P.L Alternative Data
Web Traffic
N4 Pharma Plc receives an estimated 2742 monthly visitors to n4pharma.com.
-
Web Traffic
2742
-
Change from Previous Month
124.4%
-
3 Month Change
125.1%
-
YoY Change
125.1%
Twitter Followers
N4 Pharma Plc has 923 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
923
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0%
LinkedIn Followers
600 are following N4 Pharma Plc on LinkedIn, up by 1.5% over the last month.
-
LinkedIn Followers
600
-
Daily Change
1.5%
-
1 Month Change
1.5%
-
3 Month Change
7.1%
LinkedIn Employees
According to LinkedIn, N4 Pharma Plc has 5 employees, up by 25% over the last month.
-
LinkedIn Employees
5
-
Daily Change
25%
-
1 Month Change
25%
-
3 Month Change
25%
News Mentions
N4 Pharma Plc was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
N4 Pharma Plc has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
N4P.L Financials
N4P.L Key Metrics
-
Total Revenue
£3.9K
-
Net Income
-£454.9K
-
Earnings per Share
-£0.0016
-
Free cash flow
-£390.9K
-
EBITDA
-£491.7K
-
EBITDA Ratio
-125.885
-
Total Assets
£1.3M
N4P.L 2-year Revenue & Income
N4P.L 2-year Free Cash Flow
N4P.L Technicals
N4P.L SMA
N4P.L RSI
FAQ
What's the current price of N4 Pharma Plc (N4P.L) Stock?
The price of an N4 Pharma Plc (N4P.L) share is £0.375.
What's the market cap of N4 Pharma Plc?
The current market cap of N4 Pharma Plc is 3.1M.
Should I buy or sell N4P.L?
Multiple alternative data signals suggest that N4 Pharma Plc stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is N4 Pharma Plc a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in N4 Pharma Plc stock. The bullish indicators suggest that N4 Pharma Plc's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy N4 Pharma Plc (N4P.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying N4 Pharma Plc stock, given the bullish outlook.
What are some stocks similar to N4 Pharma Plc (N4P.L) that investors often compare it to?
N4 Pharma Plc (N4P.L) is often compared to similar stocks such as Shield Therapeutics, Indivior PLC, Haleon plc, HUTCHMED (China) Limited and Hikma Pharmaceuticals PLC.
What is the forecast for N4 Pharma Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast N4 Pharma Plc's stock price to be around £0.411 in 2026. Starting from the current price of £0.375, this represents a 9.6% change in price, indicating a bullish outlook for the stock.
How to buy N4 Pharma Plc (N4P.L) Stock?
N4 Pharma Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy N4 Pharma Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.